Piramal Pharma’s Lexington facility gets two observations from USFDA

Piramal Pharma said that US Food and Drug Administration (USFDA) conducted a pre-approval inspection (PAI) at its Lexington facility, USA.

Subscribe To Our Free Newsletter

All News, Business Standard All News